Bringing innovation to patients around the world

iStock-1131857558-home

Our Mission

To transform the lives of patients living with autoimmune diseases.

Learn More

Our Pipeline

Rapidly advancing a deep portfolio of innovative autoimmune therapeutics that continues to expand through our successful business development strategy.

Learn More

Latest News

May 7, 2024

Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs

Read More

March 6, 2024

Zenas BioPharma Appoints Patricia Allen to its Board of Directors

Read More
long-arrow-right-regularfacebook-brandsfacebook-f-brandsinstagram-brandslinkedin-brandslinkedin-in-brandssubmit-arrowtwitter-brandstwitter-square-brandsyoutube-brands